Health and Wellness
Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.
The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.
The company also raised $5 million in venture debt funding.
Tampa General Hospital Cancer Institute will integrate Reimagine's platform into its clinical pathways to reduce workforce burden and extend cancer care into the home.
Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI tools that deliver measurable outcomes.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
The partnership comes three months after Thyme Care raised $97 million in funding, bringing its total raise to $275 million.
HEYDOC CEO Dr Raymond Choy explains how digital-first workflows can shoulder most care needs of small business employees, making an RM20 outpatient benefits plan possible.
This year was marked by shocking events alongside soaring company valuations, policy transformation, rapid AI adoption and landmark investments in women’s health.
Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.